SCHEMBL26528461

SCHEMBL26528461

c1nc(NC2CCCCC2)c2c(C3CCCC3)c[nH]c2n1

nearest known ligand 0.75

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 15/20 0.75
IRAK2 O43187 1/20 0.60
CLK1 P49759 1/20 0.60
CLK2 P49760 1/20 0.60
IRAK1 P51617 1/20 0.60
HASPIN Q8TF76 1/20 0.60
CLK4 Q9HAZ1 1/20 0.60
IRAK3 Q9Y616 1/20 0.60
JAK3 P52333 1/20 0.57
EGFR P00533 1/20 0.53
HPGDS O60760 1/20 0.50
LMNA P02545 2/20 0.49
HTT P42858 2/20 0.49
PKM P14618 1/20 0.49
HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26528553 0.91 IRAK4 (0.73) IRAK4IRAK2CLK1CLK2IRAK1
SCHEMBL21678424 0.87 IRAK4 (0.63) IRAK4IRAK2CLK1CLK2IRAK1
SCHEMBL21678421 0.87 IRAK4 (0.63) IRAK4IRAK2CLK1CLK2IRAK1
SCHEMBL21105711 0.86 IRAK4 (1.00) IRAK4IRAK2CLK1CLK2IRAK1
SCHEMBL21106696 0.83 IRAK4 (1.00) IRAK4IRAK2CLK1CLK2IRAK1
SCHEMBL21705145 0.82 IRAK4 (0.67) IRAK4IRAK2CLK1CLK2IRAK1
SCHEMBL21678524 0.82 IRAK4 (0.67) IRAK4IRAK2CLK1CLK2IRAK1
SCHEMBL27378229 0.81 IRAK4 (0.67) IRAK4IRAK2CLK1CLK2IRAK1
SCHEMBL21704990 0.81 IRAK4 (0.64) IRAK4IRAK2CLK1CLK2IRAK1
SCHEMBL21106698 0.80 IRAK4 (1.00) IRAK4IRAK2CLK1CLK2IRAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024092011-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2024-05-02 WO disclosed
WO-2023192586-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-10-05 WO disclosed